227 related articles for article (PubMed ID: 15728853)
1. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.
Hwang DY; Fleming SM; Ardayfio P; Moran-Gates T; Kim H; Tarazi FI; Chesselet MF; Kim KS
J Neurosci; 2005 Feb; 25(8):2132-7. PubMed ID: 15728853
[TBL] [Abstract][Full Text] [Related]
2. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
[TBL] [Abstract][Full Text] [Related]
3. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
Song B; Feldmann JW; Cao S; Feitosa M; Kong Y; Kim W; Schweitzer A; Leblanc P; Schweitzer JS; Kim KS
Neurobiol Dis; 2022 Aug; 170():105777. PubMed ID: 35636646
[TBL] [Abstract][Full Text] [Related]
4. Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.
Ding Y; Restrepo J; Won L; Hwang DY; Kim KS; Kang UJ
Neurobiol Dis; 2007 Jul; 27(1):11-23. PubMed ID: 17499513
[TBL] [Abstract][Full Text] [Related]
5. Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease.
van den Munckhof P; Gilbert F; Chamberland M; Lévesque D; Drouin J
J Neurochem; 2006 Jan; 96(1):160-70. PubMed ID: 16269007
[TBL] [Abstract][Full Text] [Related]
6. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
[TBL] [Abstract][Full Text] [Related]
7. L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.
Kleven GA; Booth HM; Voogd M; Ronca AE
Behav Neurosci; 2014 Dec; 128(6):749-59. PubMed ID: 25150543
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
Solís O; Espadas I; Del-Bel EA; Moratalla R
Neurobiol Dis; 2015 Jan; 73():49-59. PubMed ID: 25281315
[TBL] [Abstract][Full Text] [Related]
9. L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
Bhattacharjee N; Mazumder MK; Paul R; Choudhury A; Choudhury S; Borah A
Neurosci Lett; 2016 Aug; 628():225-9. PubMed ID: 27283777
[TBL] [Abstract][Full Text] [Related]
10. Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.
Ardayfio P; Moon J; Leung KK; Youn-Hwang D; Kim KS
Neurobiol Dis; 2008 Sep; 31(3):406-12. PubMed ID: 18573342
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
[TBL] [Abstract][Full Text] [Related]
12. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
13. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
14. Similar L-dopa-stimulated motor activity in mice with adult-onset 6-hydroxydopamine-induced symmetric dopamine denervation and in transcription factor Pitx3 null mice with perinatal-onset symmetric dopamine denervation.
Li L; Sagot B; Zhou FM
Brain Res; 2015 Jul; 1615():12-21. PubMed ID: 25960345
[TBL] [Abstract][Full Text] [Related]
15. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Hwang DY; Ardayfio P; Kang UJ; Semina EV; Kim KS
Brain Res Mol Brain Res; 2003 Jun; 114(2):123-31. PubMed ID: 12829322
[TBL] [Abstract][Full Text] [Related]
17. Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.
Le W; Zhang L; Xie W; Li S; Dani JA
Neurobiol Aging; 2015 Dec; 36(12):3314-3320. PubMed ID: 26363812
[TBL] [Abstract][Full Text] [Related]
18. Pitx3 is required for development of substantia nigra dopaminergic neurons.
Nunes I; Tovmasian LT; Silva RM; Burke RE; Goff SP
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4245-50. PubMed ID: 12655058
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture Alleviates Levodopa-Induced Dyskinesia via Melanin-Concentrating Hormone in Pitx3-Deficient aphakia and 6-Hydroxydopamine-Lesioned Mice.
Kim YK; Lee AR; Park H; Yoo J; Ahn S; Jeon SH; Kim J; Park HJ
Mol Neurobiol; 2019 Apr; 56(4):2408-2423. PubMed ID: 30030752
[TBL] [Abstract][Full Text] [Related]
20. Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice.
Sagot B; Li L; Zhou FM
Front Neural Circuits; 2018; 12():57. PubMed ID: 30104963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
